Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 5, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.0K

TRIM for Tissue Specificity.

Marcus D Hartmann1,2

  • 1Department of Protein Evolution, Max Planck Institute for Biology Tübingen, 72076 Tübingen, Germany.

ACS Medicinal Chemistry Letters
|January 17, 2024
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Writing the CRBN degron.

Nature chemical biology·2025
Same author

A Facile Protocol for C(sp<sup>2</sup>)-C(sp<sup>3</sup>) Bond Formation Reactions Toward Functionalized E3 Ligase Ligands.

ChemMedChem·2025
Same author

DNA Wrapping by a tetrameric bacterial histone.

Nature communications·2025
Same author

Native metabolomics identifies pteridines as CutA ligands and modulators of copper binding.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Functional Relevance of CASP16 Nucleic Acid Predictions as Evaluated by Structure Providers.

Proteins·2025
Same author

Enhancing Solubility in VHL-Based PROTACs: Optimized USP7 Degraders for Improved Developability.

Journal of medicinal chemistry·2025
Same journal

Semisynthesis of Mycothiazole Analogs having Distinct Bioactivity.

ACS medicinal chemistry letters·2026
Same journal

Investigation on the Cytotoxicity of Hydroxycinnamic and Hydroxybenzoic Acid-Based Natural Antioxidant Conjugated Terpyridine Analogues toward Triple-Negative Breast Cancer.

ACS medicinal chemistry letters·2026
Same journal

Beyond Neddylation Inhibition: X‑ray Structures Reveal Carbonic Anhydrase Isoform Selectivity of Pevonedistat.

ACS medicinal chemistry letters·2026
Same journal

Structure-Guided Discovery of Selective Polo-Like Kinase 3 Inhibitors.

ACS medicinal chemistry letters·2026
Same journal

Controlling Neuroplasticity Across Scales: Constrained Serotonergic Agonists, Neuroplastogens, and Adaptive Neuromodulation.

ACS medicinal chemistry letters·2026
Same journal

Degradation and Detection: Integrating BCL6 Targeted Protein Degradation with Biomarker-Guided BET Inhibition in Cancer.

ACS medicinal chemistry letters·2026
See all related articles

Targeted protein degradation aims for tissue-specific control, a challenge with current widely expressed E3 ligases. The TRIM58 ligase shows promise for developing tissue-specific Proteolysis Targeting Chimeras (PROTACs) and molecular glues.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Drug Discovery

Background:

  • Tissue-specific protein manipulation is a key goal in targeted protein degradation.
  • Current E3 ubiquitin ligases used in targeted protein degradation are broadly expressed, limiting tissue specificity.
  • This broad expression hinders the development of precise therapeutic strategies.

Purpose of the Study:

  • To explore the potential of the TRIM58 ligase in achieving tissue-specific protein degradation.
  • To evaluate TRIM58 as a tool for developing next-generation targeted protein degraders.

Main Methods:

  • Investigating the expression patterns and activity of the TRIM58 E3 ubiquitin ligase.
  • Assessing the feasibility of utilizing TRIM58 in targeted protein degradation strategies.

More Related Videos

Isolation of Basal Cells and Submucosal Gland Duct Cells from Mouse Trachea
11:52

Isolation of Basal Cells and Submucosal Gland Duct Cells from Mouse Trachea

Published on: September 14, 2012

14.4K
Isolate Cell-Type-Specific RNAs from Snap-Frozen Heterogeneous Tissue Samples without Cell Sorting
08:30

Isolate Cell-Type-Specific RNAs from Snap-Frozen Heterogeneous Tissue Samples without Cell Sorting

Published on: December 8, 2021

2.2K

Related Experiment Videos

Last Updated: Jul 5, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

10.0K
Isolation of Basal Cells and Submucosal Gland Duct Cells from Mouse Trachea
11:52

Isolation of Basal Cells and Submucosal Gland Duct Cells from Mouse Trachea

Published on: September 14, 2012

14.4K
Isolate Cell-Type-Specific RNAs from Snap-Frozen Heterogeneous Tissue Samples without Cell Sorting
08:30

Isolate Cell-Type-Specific RNAs from Snap-Frozen Heterogeneous Tissue Samples without Cell Sorting

Published on: December 8, 2021

2.2K
  • Analyzing the potential for TRIM58 to mediate tissue-specific protein knockdown.

    • Main Results:

    • The TRIM58 ligase presents a potential avenue for achieving tissue-specific protein degradation.
    • Its unique characteristics may overcome limitations associated with ubiquitously expressed ligases.

    Conclusions:

    • Unlocking the potential of TRIM58 could be a significant advancement for tissue-specific Proteolysis Targeting Chimeras (PROTACs) and molecular glue degraders.
    • TRIM58 offers a promising target for developing more precise and effective protein degradation therapies.